Additional file 4: of HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy NoceMarcella PainoFrancesca MeleLuigi PapaccioGianpaolo RegadTarik LombardiAngela PapaccioFederica DesiderioVincenzo TirinoVirginia 2018 Figure S2. Evaluation of CD133 marker on Saos2 and MG63 cell lines after VPA and DAC treatment. Flow cytometric analyses showed a strong increase of CD133 expression after drug treatments. ** p < 0.001, *** p < 0.0001 compared to the untreated cells. (TIF 242 kb)